P579 Risk of CMV reactivation in UC patients with previous history of CMV infection following infliximab or vedolizumab treatments

C Hommel, X Roblin, L Brichet, B Bihin, S Pillet, J -F Rahier

Résultats de recherche: Contribution à un journal/une revueArticle

langue originaleAnglais
Pages (de - à)S400-S400
journalJournal of Crohn's and Colitis
Volume12
Numéro de publicationsupplement_1
Les DOIs
étatPublié - 2 févr. 2018

Citer ceci

@article{ceb33031a2a64c05a3dfceed4bfa0c05,
title = "P579 Risk of CMV reactivation in UC patients with previous history of CMV infection following infliximab or vedolizumab treatments",
author = "C Hommel and X Roblin and L Brichet and B Bihin and S Pillet and Rahier, {J -F}",
year = "2018",
month = "2",
day = "2",
doi = "10.1093/ecco-jcc/jjx180.706",
language = "English",
volume = "12",
pages = "S400--S400",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Oxford University Press",
number = "supplement_1",

}

P579 Risk of CMV reactivation in UC patients with previous history of CMV infection following infliximab or vedolizumab treatments. / Hommel, C; Roblin, X; Brichet, L; Bihin, B; Pillet, S; Rahier, J -F.

Dans: Journal of Crohn's and Colitis, Vol 12, Numéro supplement_1, 02.02.2018, p. S400-S400.

Résultats de recherche: Contribution à un journal/une revueArticle

TY - JOUR

T1 - P579 Risk of CMV reactivation in UC patients with previous history of CMV infection following infliximab or vedolizumab treatments

AU - Hommel, C

AU - Roblin, X

AU - Brichet, L

AU - Bihin, B

AU - Pillet, S

AU - Rahier, J -F

PY - 2018/2/2

Y1 - 2018/2/2

UR - http://www.mendeley.com/research/p579-risk-cmv-reactivation-uc-patients-previous-history-cmv-infection-following-infliximab-vedolizum

U2 - 10.1093/ecco-jcc/jjx180.706

DO - 10.1093/ecco-jcc/jjx180.706

M3 - Article

VL - 12

SP - S400-S400

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - supplement_1

ER -